EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Phenotypic expression of rare progressive cardiac conduction disease variants in the general population

Ravi A Shah iD, Julia Ramírez iD, Claire Kirkby iD, Charlotte Ives, Martin Lowe, Patricia B Munroe iD, Pier D Lambiase iD, William J Young iD

Europace · 2025

DOI: 10.1093/europace/euaf103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2025. Verfasst von Ravi A Shah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Science, University College London, Rayne Building, University Street, London WC1E 6BT, UK. Hauptthemen laut MEDLINE: Cardiac Conduction System Disease, Atrioventricular Block. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute for Health and Care Research, University College London, University College London Hospitals & Barts Biomedicine NIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Familial progressive cardiac conduction disease (PCCD) is a heritable condition leading to conduction defects that may require pacemaker implantation. The penetrance of rare PCCD variants in general populations and relationship with electrocardiogram (ECG) trait polygenic risk scores (PRS) is unknown. We investigated the prevalence and phenotypic expression of rare variants linked with PCCD in a population cohort and to establish whether ECG-trait PRSs improve risk prediction. Methods and results Carriers of known rare pathogenic/likely pathogenic (P/LP) PCCD variants, and variants of uncertain significance (VUS) were identified in 469 511 UK Biobank participants. Primary (any conduction disease) and secondary (high-grade AV block and pacemaker implantation) outcomes were evaluated in lifetime-risk Cox proportional hazard models including rare variant status, sex, and age. Additional models including PR and QRS PRSs were tested. There were 25 P/LP carriers (5 genes) and 3174 VUS carriers (4 genes). Conduction disease was more prevalent in P/LP individuals compared with non-carriers (28% vs. 5.3%, P < 0.001) with a hazard ratio (HR) of 6.60 (95% CI = 3.14–13.8) over 6.5 million person-years of follow-up and C-index 0.602 (0.599–0.605). This was driven by AV block (HR 23.2 [8.7–61.8]) and pacemaker implantation (HR 13.4 [6.01–29.8]). All individuals were aged >50 at diagnosis. Combined with P/LP status, PR-PRS and QRS-PRS improved model performance (C-index 0.618 [0.615–0.622]).

Conclusion

In a population-based cohort, PCCD P/LP variant carriers were at greater risk of conduction disease. Including PRSs for the PR and QRS improved risk prediction, supporting the combination of rare and common variants in risk assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Conduction System DiseaseAtrioventricular BlockHumansMaleFemaleMiddle AgedPhenotypeElectrocardiographyAgedUnited KingdomGenetic Predisposition to DiseaseRisk AssessmentPrevalenceRisk FactorsAction PotentialsAdultPacemaker, ArtificialDisease ProgressionPenetranceMultifactorial Inheritance

Stichwörter der Autor:innen

Atrioventricular blockGenetic risk scoreInherited cardiovascular diseasePenetranceUK Biobank

Autor:innen und Institutionen

  • Institute of Cardiovascular Science, University College London, Rayne Building, University Street, London WC1E 6BT, UK.
  • Centre for Clinical Pharmacology and Precision Medicine, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Aragon Institute of Engineering Research, University of Zaragoza, Zaragoza, Spain.
  • Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina, Zaragoza, Spain.
  • Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

ORCID-Profile: Ravi A Shah, Julia Ramírez, Claire Kirkby, Patricia B Munroe, Pier D Lambiase, William J Young

Förderung

  • National Institute for Health and Care Research
  • University College London
  • University College London Hospitals & Barts Biomedicine NIHR
  • British Heart Foundation
  • the Stephen Lyness Memorial Fund
  • NIHR Integrated Academic Training programme
  • NIHR Barts Biomedical Research Centre
  • Barts Health NHS Trust

Zitieren

APA

Shah, R. A., Ramírez, J., Kirkby, C., Ives, C., Lowe, M., Munroe, P. B., Lambiase, P. D., & Young, W. J. (2025). Phenotypic expression of rare progressive cardiac conduction disease variants in the general population. Europace. https://doi.org/10.1093/europace/euaf103

Vancouver

Shah RA, Ramírez J, Kirkby C, Ives C, Lowe M, Munroe PB, et al. Phenotypic expression of rare progressive cardiac conduction disease variants in the general population. Europace. 2025. doi:10.1093/europace/euaf103

BibTeX
@article{Shah2025,
  author = {Shah, Ravi A and Ramírez, Julia and Kirkby, Claire and Ives, Charlotte and Lowe, Martin and Munroe, Patricia B and Lambiase, Pier D and Young, William J},
  title = {Phenotypic expression of rare progressive cardiac conduction disease variants in the general population},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf103}
}
Kostenlos starten →